17165277

Source:http://linkedlifedata.com/resource/pubmed/id/17165277

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0087111, umls-concept:C0205322, umls-concept:C0298130, umls-concept:C0908935, umls-concept:C1174893, umls-concept:C2607914
pubmed:issue	5
pubmed:dateCreated	2006-12-14
pubmed:abstractText	Montelukast sodium is approved as a treatment for intermittent and persistent allergic rhinitis (AR), but it has not been evaluated as combined therapy with antihistamines for persistent AR.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9503580
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Acetates, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Asthmatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cetirizine, http://linkedlifedata.com/resource/pubmed/chemical/Eosinophil Cationic Protein, http://linkedlifedata.com/resource/pubmed/chemical/Histamine H1 Antagonists..., http://linkedlifedata.com/resource/pubmed/chemical/Loratadine, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Quinolines, http://linkedlifedata.com/resource/pubmed/chemical/RNASE3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/desloratadine, http://linkedlifedata.com/resource/pubmed/chemical/levocetirizine, http://linkedlifedata.com/resource/pubmed/chemical/montelukast
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1081-1206
pubmed:author	pubmed-author:CiebiadaMaciejM, pubmed-author:DoodyKevin JKJ, pubmed-author:DuBuskeLawrence MLM, pubmed-author:GórskiPawe?P
pubmed:issnType	Print
pubmed:volume	97
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	664-71
pubmed:meshHeading	pubmed-meshheading:17165277-Acetates, pubmed-meshheading:17165277-Adolescent, pubmed-meshheading:17165277-Adult, pubmed-meshheading:17165277-Aged, pubmed-meshheading:17165277-Anti-Asthmatic Agents, pubmed-meshheading:17165277-Cetirizine, pubmed-meshheading:17165277-Cross-Over Studies, pubmed-meshheading:17165277-Double-Blind Method, pubmed-meshheading:17165277-Drug Therapy, Combination, pubmed-meshheading:17165277-Eosinophil Cationic Protein, pubmed-meshheading:17165277-Female, pubmed-meshheading:17165277-Histamine H1 Antagonists, Non-Sedating, pubmed-meshheading:17165277-Humans, pubmed-meshheading:17165277-Loratadine, pubmed-meshheading:17165277-Male, pubmed-meshheading:17165277-Middle Aged, pubmed-meshheading:17165277-Nasal Lavage Fluid, pubmed-meshheading:17165277-Piperazines, pubmed-meshheading:17165277-Quinolines, pubmed-meshheading:17165277-Rhinitis, Allergic, Perennial, pubmed-meshheading:17165277-Rhinometry, Acoustic, pubmed-meshheading:17165277-Treatment Outcome
pubmed:year	2006
pubmed:articleTitle	Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
pubmed:affiliation	Department of Pneumology and Allergy, Medical University of Lodz, Lodz, Poland.
pubmed:publicationType	Journal Article, Randomized Controlled Trial